BR112022022471A2 - Síntese de intermediários de vinilciclobutila - Google Patents
Síntese de intermediários de vinilciclobutilaInfo
- Publication number
- BR112022022471A2 BR112022022471A2 BR112022022471A BR112022022471A BR112022022471A2 BR 112022022471 A2 BR112022022471 A2 BR 112022022471A2 BR 112022022471 A BR112022022471 A BR 112022022471A BR 112022022471 A BR112022022471 A BR 112022022471A BR 112022022471 A2 BR112022022471 A2 BR 112022022471A2
- Authority
- BR
- Brazil
- Prior art keywords
- synthesis
- intermediates
- vinylcyclobutyl
- compound
- salt
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 3
- 239000000543 intermediate Substances 0.000 title abstract 3
- 238000003786 synthesis reaction Methods 0.000 title abstract 3
- -1 VINYLCYCLOBUTYL Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 230000002194 synthesizing effect Effects 0.000 abstract 2
- SFHYNDMGZXWXBU-LIMNOBDPSA-N 6-amino-2-[[(e)-(3-formylphenyl)methylideneamino]carbamoylamino]-1,3-dioxobenzo[de]isoquinoline-5,8-disulfonic acid Chemical compound O=C1C(C2=3)=CC(S(O)(=O)=O)=CC=3C(N)=C(S(O)(=O)=O)C=C2C(=O)N1NC(=O)N\N=C\C1=CC=CC(C=O)=C1 SFHYNDMGZXWXBU-LIMNOBDPSA-N 0.000 abstract 1
- 101001056180 Homo sapiens Induced myeloid leukemia cell differentiation protein Mcl-1 Proteins 0.000 abstract 1
- 102100026539 Induced myeloid leukemia cell differentiation protein Mcl-1 Human genes 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/62—Use of additives, e.g. for stabilisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/23—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/14—Preparation of carboxylic acid esters from carboxylic acid halides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SÍNTESE DE INTERMEDIÁRIOS DE VINILCICLOBUTILA. São proporcionados aqui processos para sintetizar intermediários úteis na preparação de inibidores de Mcl-1. Em particular são proporcionados aqui processos para sintetizar o composto F, ou um seu sal, em que R1 e OPG2 são descritos aqui. O composto F pode ser útil na síntese do composto A1, ou um seu sal ou solvato, ou do composto A2 ou um seu sal ou solvato.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063020877P | 2020-05-06 | 2020-05-06 | |
PCT/US2021/030548 WO2021226009A1 (en) | 2020-05-06 | 2021-05-04 | Synthesis of vinyl cyclobutyl intermediates |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022022471A2 true BR112022022471A2 (pt) | 2022-12-13 |
Family
ID=76197567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022022471A BR112022022471A2 (pt) | 2020-05-06 | 2021-05-04 | Síntese de intermediários de vinilciclobutila |
Country Status (18)
Country | Link |
---|---|
US (1) | US20230183164A1 (pt) |
EP (1) | EP4146634A1 (pt) |
JP (2) | JP7494318B2 (pt) |
KR (1) | KR20230006552A (pt) |
CN (1) | CN115485267A (pt) |
AR (1) | AR122000A1 (pt) |
AU (1) | AU2021268617B2 (pt) |
BR (1) | BR112022022471A2 (pt) |
CA (1) | CA3181213A1 (pt) |
CL (1) | CL2022003054A1 (pt) |
CO (1) | CO2022015976A2 (pt) |
CR (1) | CR20220622A (pt) |
IL (1) | IL297523A (pt) |
MX (1) | MX2022013870A (pt) |
PE (1) | PE20230465A1 (pt) |
TW (1) | TWI867217B (pt) |
UY (1) | UY39200A (pt) |
WO (1) | WO2021226009A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118908912A (zh) * | 2020-05-06 | 2024-11-08 | 安进公司 | 乙烯基保护的醇中间体的合成 |
CA3202548A1 (en) * | 2020-11-25 | 2022-06-02 | Amgen Inc. | Enantioselective alkenylation of aldehydes |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3474B1 (ar) * | 2014-08-29 | 2020-07-05 | Amgen Inc | مشتقات تيتراهيدرونافثالين التي تثبط بروتين mcl-1 |
US11306107B2 (en) * | 2016-02-25 | 2022-04-19 | Amgen Inc. | Compounds that inhibit MCL-1 protein |
JP6453507B2 (ja) * | 2017-03-30 | 2019-01-16 | アムジエン・インコーポレーテツド | Mcl−1タンパク質を阻害する化合物 |
TWI778443B (zh) * | 2019-11-12 | 2022-09-21 | 美商基利科學股份有限公司 | Mcl1抑制劑 |
CN114787139B (zh) * | 2019-11-26 | 2025-03-11 | 吉利德科学公司 | 用于制备mcl1抑制剂的方法和中间体 |
-
2021
- 2021-04-29 TW TW110115527A patent/TWI867217B/zh active
- 2021-05-04 AU AU2021268617A patent/AU2021268617B2/en active Active
- 2021-05-04 MX MX2022013870A patent/MX2022013870A/es unknown
- 2021-05-04 CA CA3181213A patent/CA3181213A1/en active Pending
- 2021-05-04 AR ARP210101208A patent/AR122000A1/es not_active Application Discontinuation
- 2021-05-04 US US17/920,084 patent/US20230183164A1/en active Pending
- 2021-05-04 IL IL297523A patent/IL297523A/en unknown
- 2021-05-04 KR KR1020227042181A patent/KR20230006552A/ko active Pending
- 2021-05-04 BR BR112022022471A patent/BR112022022471A2/pt unknown
- 2021-05-04 CN CN202180032530.2A patent/CN115485267A/zh active Pending
- 2021-05-04 CR CR20220622A patent/CR20220622A/es unknown
- 2021-05-04 EP EP21729090.7A patent/EP4146634A1/en active Pending
- 2021-05-04 WO PCT/US2021/030548 patent/WO2021226009A1/en not_active Application Discontinuation
- 2021-05-04 JP JP2022566645A patent/JP7494318B2/ja active Active
- 2021-05-04 PE PE2022002563A patent/PE20230465A1/es unknown
- 2021-05-06 UY UY0001039200A patent/UY39200A/es unknown
-
2022
- 2022-11-04 CL CL2022003054A patent/CL2022003054A1/es unknown
- 2022-11-08 CO CONC2022/0015976A patent/CO2022015976A2/es unknown
-
2024
- 2024-03-05 JP JP2024032723A patent/JP2024095652A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
UY39200A (es) | 2021-11-30 |
JP7494318B2 (ja) | 2024-06-03 |
CL2022003054A1 (es) | 2023-06-30 |
US20230183164A1 (en) | 2023-06-15 |
CA3181213A1 (en) | 2021-11-11 |
KR20230006552A (ko) | 2023-01-10 |
CR20220622A (es) | 2023-01-24 |
PE20230465A1 (es) | 2023-03-14 |
EP4146634A1 (en) | 2023-03-15 |
TW202208342A (zh) | 2022-03-01 |
CO2022015976A2 (es) | 2022-12-09 |
IL297523A (en) | 2022-12-01 |
AU2021268617B2 (en) | 2024-06-13 |
JP2024095652A (ja) | 2024-07-10 |
MX2022013870A (es) | 2022-11-30 |
AR122000A1 (es) | 2022-08-03 |
AU2021268617A1 (en) | 2022-12-15 |
JP2023524259A (ja) | 2023-06-09 |
TWI867217B (zh) | 2024-12-21 |
WO2021226009A1 (en) | 2021-11-11 |
CN115485267A (zh) | 2022-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112022022400A2 (pt) | Síntese de intermediários de álcool vinílico protegidos | |
BR112022022471A2 (pt) | Síntese de intermediários de vinilciclobutila | |
CR20230598A (es) | Inhibidores de cdk2 | |
BR112021023824A2 (pt) | Inibidor de proteína quinase dependente de dna | |
BR112021017049A2 (pt) | Derivados de tiazol como inibidores de secreção de proteínas | |
AR057874A1 (es) | Aminopirimidinas utiles como inhibidores de quinasa | |
BRPI0613429A2 (pt) | inibidores de histona desacetilase | |
CL2019002019A1 (es) | Nuevo compuesto heterocíclico, su método de preparación y composición farmacéutica que lo comprende. | |
AR074438A1 (es) | Proceso para la modulacion de la actividad antagonista de un anticuerpo monoclonal | |
PE20231308A1 (es) | Proceso e intermedios para preparar un inhibidor de jak1 | |
PE20250667A1 (es) | Formas solidas, sales y procesos de preparacion de un inhibidor de cdk2 | |
BR112022022434A2 (pt) | Síntese de fecho do anel de intermediários de inibidores de mcl-1 macrocíclicos | |
CO2022013968A2 (es) | Preparación del compuesto inhibidor de mcl-1 por metilación en presencia de agua. | |
BR112023000350A2 (pt) | Sais e formas de um inibidor de wee1 | |
CU20210016A7 (es) | Dioxociclobutenilamino-3-hidroxi-picolinamidas n-sustituidas útiles como inhibidores de ccr6 | |
BR112022022474A2 (pt) | Síntese de intermediários de sulfonamida | |
DOP2023000277A (es) | Pirimidinil-pirazoles sustituidos como inhibidores de cdk2 | |
CL2024002379A1 (es) | Composición farmacéutica y que comprende derivados de difenildiazol métodos de uso | |
CL2023003921A1 (es) | Inhibidores de transglutaminasas | |
MX2019001053A (es) | Inhibidores de antigeno de la membrana especifico para la prostata (psma) quelados. | |
BR112023010228A2 (pt) | Alquenilação enantiosseletiva de aldeídos | |
MX2024008385A (es) | Inhibidor de la corrosion. | |
BR112022022408A2 (pt) | Síntese de intermediários de álcool vinílico | |
CO2024009342A2 (es) | Sal derivada de triazolona como inhibidor de elastasa de neutrófilos | |
ECSP24007534A (es) | Inhibidores de transglutaminasas |